Courage Therapeutics INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersNewton Center, MA
SAM.gov UEIW841GEJ8ADX7
Brands
Tomi
Sasha
GeorgeThis company sells these brands.
Courage Therapeutics develops precision therapeutics for genetic obesities, specifically targeting melanocortin-4 receptor haploinsufficiency (MC4R HI). The company's lead candidate, CTX-B, is a weekly injectable agonist that acts on the MC4R pathway to restore pathway activity and reduce hyperphagia in patients with MC4R pathway-driven obesity. The company serves patients with genetic obesity caused by MC4R pathway mutations.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Courage Therapeutics INC | Newton Center | MA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.


